Matinas BioPharma Holdings, Inc. - Common Stock, $0.0001 par value per share (MTNB)

CUSIP: 576810303

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
-29,309
SEC-reported price per share
$0.61
Number of holders
25
Value change
-$15,595
Number of buys
7
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,694,843

Security key

576810303

Report period

Q2 2026

Institutions

25

Top holders

10

Ownership snapshot

Top reported holders of MTNB - Matinas BioPharma Holdings, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Pembroke & Partners LLC
Disclosed value leader
Pembroke & Partners LLC
Comparable rows
3/15
Latest evidence
10 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 10% 12 rows are not safely comparable across share classes. 13D/G row: Pembroke & Partners LLC Showing 1-6 of 15 holder rows.

Quick read

Pembroke & Partners LLC leads the comparable SEC ownership view at 10%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pembroke & Partners LLC's linked filing trail.
Comparable ownership Top 3
Pembroke & Partners LLC 10%
David E. Lazar 9.8%
111 Equity Group 3.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Pembroke & Partners LLC
13D/G 3/4/5
Robert J. Eide · 10%+ Owner
10%
Reported 13D/G · 08 Apr 2025
$10,137,427
16,895,712 shares
+$9,526,394 08 Apr 2025
David E. Lazar
13D/G
Lazar David E.
9.8%
Reported 13D/G · 15 Aug 2025
$517,750
545,000 shares
$0 15 Aug 2025
111 Equity Group
13D/G
111 Equity Group LLC
3.6%
Reported 13D/G · 13 Feb 2025
$110,183
183,639 shares
-$47,617 13 Feb 2025
Adam K. Stern
3/4/5
10%+ Owner
—
mixed-class rows
$591,092
2,559,005 shares
mixed-class rows
— 16 Oct 2025
Sanitam Partners LLC
3/4/5
10%+ Owner
—
denominator unverified
—
4,798,636 shares
— 10 Jun 2026
Robert J. Eide
3/4/5
10%+ Owner
—
mixed-class rows
—
3,360,848 shares
mixed-class rows
— 08 Apr 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
25
Shares
325,055
Rows available
25
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
28
Q2 2026 holders
25
Holder diff
-3
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .